Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In this blog, we identify the likely market challenges posed by GLP-1 agonists and the possible ways to prevent disruptions in your supply chain
first since 2014
Key Takeaways Market Scale : The GLP-1 market is projected to exceed $200 billion by 2033, making it the most significant therapeutic class for capital allocation in the next decade
Both companies have previously told FOX Business that they have been engaged in discussions with the administration to increase affordability and expand patient access to their drugs, aligning with the administration's Most Favored Nation executive order which seeks to lower drug prices in the U.S
One woman says her gastroparesis lasted for at least a year after she stopped taking Ozempic, and it required her to take time off work
US$ 20.87
US$ 28.33
US$ 22.95
US$ 23.63
US$ 26.24
US$ 24.09
